HIGHLIGHTS
- who: Hao Zhang from the Jackson Laboratory, United States Department of Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science have published the paper: The landscape of chimeric antigen receptor T cell therapy in breast cancer: Perspectives and outlook, in the Journal: (JOURNAL)
- what: This study demonstrated that CAR-T_cells can effectively overcome antibody therapy failure by masking the tumor epitope and blocking the tumor stroma revolutionized the mainstream treatment concept for HER2positive breast cancer.
- how: In this review the authors introduced the novel CAR-T_cell engineering strategy summarized the potential targets . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.